Compare · CHE vs HIMS
CHE vs HIMS
Side-by-side comparison of Chemed Corp (CHE) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $6.85B, about the same size as CHE ($6.74B).
- HIMS has been more active in the news (10 items in the past 4 weeks vs 6 for CHE).
- HIMS has more recent analyst coverage (25 ratings vs 7 for CHE).
- Company
- Chemed Corp
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $6.74B
- $6.85B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 6
- 10
- Recent ratings
- 7
- 25
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest CHE
- Executive vice president Lee Spencer S exercised 12,099 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 11,160 units of Capital Stock, increasing direct ownership by 7% to 14,851 units (SEC Form 4)
- Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28
- President and CEO Mcnamara Kevin J sold $1,026,900 worth of Capital Stock (2,000 units at $513.45), decreasing direct ownership by 3% to 66,418 units (SEC Form 4)
- Vice president Hutton Thomas C exercised 4,629 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 4,270 units of Capital Stock, increasing direct ownership by 1% to 32,840 units (SEC Form 4)
- UBS initiated coverage on Chemed with a new price target
- President and CEO Mcnamara Kevin J sold $1,002,800 worth of Capital Stock (2,000 units at $501.40), decreasing direct ownership by 3% to 68,418 units (SEC Form 4)
- Roto-Rooter Buys Largest Franchisee Territory
- Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
Latest HIMS
- SEC Form 4 filed by Hims & Hers Health Inc.
- SEC Form 3 filed by Hims & Hers Health Inc.
- Hims & Hers to Announce Third Quarter 2026 Financial Results on November 9, 2026
- Hers Launches in Australia, Built to Care for the Whole Woman
- SEC Form 8-K filed by Hims & Hers Health Inc.
- Hims & Hers Names Jon Franklin as Chief Accounting Officer
- Chief Financial Officer Okupe Oluyemi sold $59,400 worth of shares (2,000 units at $29.70) as part of a pre-agreed trading plan, decreasing direct ownership by 0.85% to 234,527 units (SEC Form 4)
- Chief Legal Officer Boughton Soleil sold $100,957 worth of shares (3,461 units at $29.17) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 300,809 units (SEC Form 4)
- Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
- Chief Financial Officer Okupe Oluyemi sold $876,846 worth of shares (29,277 units at $29.95) as part of a pre-agreed trading plan and exercised 14,000 shares at a strike of $5.01, decreasing direct ownership by 6% to 236,527 units (SEC Form 4)